NCT00876070View on ClinicalTrials.gov

Community Oncology Setting Cost Analysis and Disease Outcomes of Taxane Use in Metastatic Breast Cancer

CompletedOBSERVATIONAL
Enrollment

198

Participants

Timeline

Start Date

November 30, 2008

Primary Completion Date

November 30, 2009

Study Completion Date

February 28, 2011

Conditions
Metastatic Breast Cancer
Trial Locations (2)

30341

Georgia Cancer Specialists, Atlanta

37023

Tennessee Oncology, PLLC, Nashville

Sponsors

Collaborators (1)

Celgene Corporation
All Listed Sponsors
collaborator

Celgene Corporation

INDUSTRY

lead

SCRI Development Innovations, LLC

OTHER

NCT00876070 - Community Oncology Setting Cost Analysis and Disease Outcomes of Taxane Use in Metastatic Breast Cancer | Biotech Hunter | Biotech Hunter